| Angiotech Pharmaceuticals announced the commercial launch of the Tan EndoGlide Endothelium Insertion System in the U.S. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System, which it obtained in a supply agreement with privately held Network Medical Products, Ltd. Angiotech will launch the product during the American Academy of Ophthalmology meeting, to be held in San Francisco, CA on October 24-27, 2009. :theflyonthewall.com |
